(Competitive Insight/Unsplash) While GLP-1 drugs such as Wegovy and Ozempic are now being broadly championed and widely used, ...

The weight-loss drugs market is set to grow to around Rs 5,000 crore in India by 2030, up from Rs 1,000 crore at present, ...

A bull Put options strategy is favored over direct equity due to AMPH’s lack of moat or high growth. My last article about Amphastar Pharmaceuticals, Inc. ( AMPH) was in July, last year. This is a ...

The blockbuster GLP-1 drugs that reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce their tragic outcomes, a large new study found.

Tetratherix launches precision medicine franchise via Tetramatrix; signs exclusive US$3m/year deal with Superpower Health for ...

A review in the Canadian Journal of Physiology and Pharmacology examines emerging evidence linking glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the gut microbiome, and obesity treatment ...

Hormone therapy for menopause is safer than doctors had previously thought, new research says. It may also bring unexpected ...

John "Gabe" Horneff, an orthopedic surgeon at Pennsylvania Hospital, had noticed a peculiar trend: Some patients taking ...